Form 4: Omada Health Director Acquires Shares

Omada Health Director Adam Stavisky acquired 10,882 shares of common stock through restricted stock units.

Summary

• Adam Stavisky, a Director at Omada Health, Inc., acquired 10,882 shares of common stock on June 16, 2026.
• These shares were acquired through restricted stock units (RSUs) which entitle the holder to one share of common stock per RSU upon vesting.
• The RSUs are set to fully vest on the earlier of the first anniversary of the grant date or the date of the 2027 Annual Meeting of stockholders, provided the reporting person remains in service.
• Following this transaction, Adam Stavisky beneficially owns 20,618 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard RSU vesting and acquisition by a director, rather than a significant new investment or divestment.

Positives

• Director acquisition of shares can signal confidence in the company's future prospects.
• The acquisition is through RSUs, indicating a form of long-term incentive compensation tied to continued service and vesting schedules.

Risks

• The vesting of RSUs is contingent on continued service, meaning a departure before the vesting date would result in forfeiture of the unvested portion.
• The value of the acquired shares is subject to market fluctuations and the company's future performance.

Future Outlook

The restricted stock units are scheduled to fully vest on the earlier of the first anniversary of the grant date or the date of the 2027 Annual Meeting of stockholders, subject to continued service.

Industry Context

StockSavvy.ai notes that insider transactions, such as this acquisition of shares by a director, are common in the health tech sector as a way to align executive interests with shareholder value and signal confidence.

Stakeholder Impact

• Shareholders: The acquisition by a director may be viewed positively, suggesting confidence in the company's future performance, but it does not represent a new capital injection or significant change in ownership structure.

Next Steps

• Vesting of the RSUs on the earlier of the first anniversary of the grant date or the 2027 Annual Meeting of stockholders, subject to continued service.

Key Dates

Keywords

Omada Health, OMDA, Form 4, Insider Trading, Restricted Stock Units, RSU, Director, Beneficial Ownership, Securities Acquisition